864
Views
25
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: A phase II study

, , , , &
Pages 27-32 | Received 15 Aug 2009, Accepted 08 Jun 2010, Published online: 21 Sep 2010

References

  • Vertrees RA, Das GC, Popov VL, Coscio AM, Goodwin TJ, Logrono R, Zwischenberger JB, Boor PJ. Synergistic Interaction of Hyperthermia and Gemcitabine. Cancer Biol Ther 2005; 4: 1144–1153
  • Pereira S, Fernandes PA, Ramos MJ. Mechanism for ribonucleotide reductase inactivation by the anticancer drug gemcitabine. J Comput Chem 2004; 25: 1286–1294
  • Rosell R, Danenberg KD, Alberola V, Bepler G, Sanchez JJ, Camps C, Provencio M, Isla D, Taron M, Diz P, Artal A. Spanish Lung Cancer Group. Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced nonsmall cell lung cancer patients. Clin Cancer Res 2004; 10: 1318–1325
  • Pace E, Melis M, Siena L, Bucchieri F, Vignola AM, Profita M, Gjomarkaj M, Bonsignore G. Effects of gemcitabine on cell proliferation and apoptosis in nonsmall-cell lung cancer (NSCLC) cell lines. Cancer Chemother Pharmacol 2000; 46: 467–476
  • Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–247. doi: 10.1016/j.ejca.2008.10.026.
  • Kaba H, Fukuda H, Yamamoto S, Ohashi Y. Reliability at the National Cancer Institute-Common Toxicity Criteria version 2.0. Gan To Kagaku Ryoho. 2004 Aug;31(8):1187–1192.
  • Van der Zee J. Heating the patient A promising approach?. Ann Oncol 2002; 13: 1173–1184
  • Mohamed F, Marchettini P, Stuart OA, Urano M, Sugarbaker PH. Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia. Ann Surg Oncol 2003; 10: 463–468
  • Nagle VLJ, Berry JM, Bull JM. Whole body hyperthermia with carboplatin (CBDCA) for treatment of advanced or metastatic GI adenocarcinomas. Proc Am Assoc CA Res 1999; 40: 345
  • Karino T, Koga S, Maeta M. Experimental studies of the effects of local hyperthermia on blood flow, oxygen pressure and pH in tumors. Jpn J Surg 1988; 18: 276–283
  • Song CW. Effect of local hyperthermia on blood flow and micro-environment. Cancer Res 1984; 44: 4721–4730
  • Engin K. Biological rationale and clinical experience with hyperthermia. Control Clin Trials 1996; 17: 316–342
  • Feyerabend T. Rationale and clinical status of local hyperthermia, radiation and chemotherapy in locally advanced malignancies. Anticancer Res 1997; 17: 2895–2897
  • Issels R. Hyperthermia combined with chemotherapy: Biological rationale, clinical application and treatment results. Oncology 1999; 22: 374–381
  • Matthew CB. Hyperthermia-induced changes in the vascular permeability of rats: A model system to examine therapeutic interventions. J Thermal Biol 2000; 25: 381–386
  • Massing U. Cancer therapy with liposomal formations of anti-cancer drugs. Int J Clin Pharm Ther 1997; 35: 87–90
  • Huang SK, Stauffer PR, Hong K, Guo JW, Phillips TL, Huang A, Papahadjopoulos D. Liposomes and hyperthermia in mice: Increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res 1994; 54: 2186–2191
  • Kong G, Dewhirst MW. Hyperthermia and liposomes. Int J Hyperthermia 1999; 15: 345–370
  • Maruyama K, Unezaki S, Takahashi N, Iwatsuru M. Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia. Biochim Biophys Acta 1993; 1149: 209–216
  • Unezaki S, Maruyama K, Takahashi N, Koyama M, Yuda T, Suginaka A, Iwatsuru M. Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia. Pharm Res 1994; 11: 1180–1185
  • Fujiwara K, Watanabe T. Effects of hyperthermia radiotherapy and thermoradiotherapy on tumor microvascular permeability. Acta Pathol Jpn 1990; 40: 79–84
  • Gaber MH, Wu NZ, Hong K, Huang SK, Dewhirst MW, Papahadjopoulos D. Thermosensitive liposomes: Extravasation and release of contents in tumor microvascular networks. Int J Radiat Oncol Biol Phys 1996; 36: 1177–1187
  • Hauck ML, Coffin DO, Dodge RK, Dewhirst MW, Mitchell JB, Zalutsky MR. A local hyperthermia treatment which enhances antibody uptake in a glioma xenograft model does not affect tumor interstitial fluid pressure. Int J Hyperthermia 1997; 13: 307–316
  • Kong G, Braun RD, Dewhirst MW. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res 2001; 61: 3027–3032
  • Lefor A, Makohon S, Ackerman N. The effects of hyperthermia on vascular permeability in experimental liver metastasis. J Surg Oncol 1985; 28: 297–300
  • Dudar T, Jain R. Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res 1984; 44: 605–612
  • Eddy HA. Alterations in tumor microvasculature during hyperthermia. Radiology 1980; 137: 515–521
  • Moriyama E. Cerebral blood flow changes during localized hyperthermia. Neurol Med Chir 1990; 30: 923–929
  • Nishimura Y, Hiraoka M, Jo S, Akuta K, Yukawa Y, Shibamoto Y, Takahashi M, Abe M. Microangiographic and histologic analysis of the effects of hyperthermia on murine tumor microvasculature. Int J Radiat Oncol Biol Phys 1988; 15: 411–420

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.